There is a lot of buzz over recent energy activity in Sub-Saharan Africa. With Anadarko Petroleum (NYSE: APC ) and Eni (NYSE: E ) making large gas finds off the coast of Mozambique, several majors are now looking to get in the game as well. BP plans to spend $540 million over the next five years to develop a part of this gas field that could hold well over 100 trillion cubic feet.�
Better drilling technology and relative political stability in the region have allowed several companies to start investing money in the region, and if some of these plays hit paydirt, some companies could be in for big paydays. In this video, Fool.com contributor Tyler Crowe talks with Aimee Duffy about some of the hot energy plays on the African continent and what we should expect from this region in the years to come. �
With more than 94% of its capital investments coming in the international markets for 2013, National Oilwell Varco is positioning itself to be the leader in oil services around the world. To help determine whether it could be a good fit for your portfolio, you're invited to check out The Motley Fool's premium research report featuring in-depth analysis on whether NOV is a buy today. For instant access to this valuable investor's resource, simply click here now to claim your copy.
Top Beverage Stocks To Watch Right Now: Qiagen N.V.(QGEN)
QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company?s consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non- cGMP DNA production on a contract basis. The company?s instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.
Advisors' Opinion:- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
Qiagen N.V (QGEN).’s test to quantify viral loads on organ transplant patients has been approved by the U.S. Food and Drug Administration under a full premarket approval. The Artus CMV RCQ MDx Kit is the only FDA-approved, polymerase chain reaction-based assay optimized for low- to mid-throughput testing of human cytomegalovirus.
Top Oil Service Stocks To Watch Right Now: Senomyx Inc.(SNMX)
Senomyx, Inc. engages in the discovery and development of novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas using proprietary taste receptor-based assays and screening technologies. The company has product discovery, development, and commercialization collaborations with seven food, beverage, and ingredient companies, including Ajinomoto Co., Inc.; Firmenich SA; Kraft Foods, Inc.; Nestle SA; and PepsiCo, Inc. Senomyx, Inc. licenses flavor ingredients to its collaborators on an exclusive or co-exclusive basis. The company was founded in 1998 and is based in San Diego, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV). - [By Roberto Pedone]
Senomyx (SNMX) discovers, develops and commercializes flavor ingredients for the packaged food, beverage and ingredient supply industries using proprietary taste receptor-based assays and screening technologies. This stock closed up 10.4% to $8.49 in Thursday's trading session.
Thursday's Range: $7.70-$8.62
52-Week Range: $3.27-$12.74
Thursday's Volume: 622,000
Three-Month Average Volume: 425,867From a technical perspective, SNMX ripped sharply higher here right above some near-term support at $7.66 and back above its 50-day moving average of $8.68 with above-average volume. This stock has formed a major bottoming chart pattern over the last month and change, with shares finding buying interest at $7.39, $7.55 and $7.66 a share. Shares of SNMX are now starting to spike sharply higher above those support levels and it's quickly moving within range of triggering a major breakout trade. That trade will hit if SNMX manages to take out its 50-day moving average of $8.68 and then once it clears more key overhead resistance levels at $9.38 to $10.11 with high volume.
Traders should now look for long-biased trades in SNMX as long as it's trending above its 200-day at $8.04 or above some more near-term support at $7.66 and then once it sustains a move or close above those breakout levels with volume that hits near or above 425,867 shares. If that breakout triggers soon, then SNMX will set up to re-test or possibly take out its next major overhead resistance levels at $12 to its 52-week high at $12.74.
Top Oil Service Stocks To Watch Right Now: Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp., incorporated in 1993, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threatening genetic conditions. Its lead program, SBC-102, recombinant human lysosomal acid lipase (LAL), is its advanced pipeline program in clinical development for LAL Deficiency. This enzyme is responsible for the metabolism of cholesteryl esters and triglycerides that are delivered to lysosomes by a variety of routes, including low-density lipoprotein receptor mediated endocytosis. On November 2, 2012, Trimeris, Inc. merged with Synageva BioPharma Corp.
SBC-102 is produced by recombinant deoxyribonucleic acid (DNA) technology in egg white using its protein manufacturing platform. The Company has initiated natural history studies in approximately 20 countries. In addition to SBC-102, it is progressing protein therapeutic programs for other rare diseases, which are at different stages of preclinical development. These include two enzyme replacement therapies for other lysosomal storage disorders and two programs for other rare life-threatening conditions. As of December 31, 2011, its product candidate pipeline included SBC-102, SBC-103, SBC-104, SBC-105 and SBC-106.
SBC-104 is an extracellular protein that targets a severe, rare genetic condition. SBC-105 is an enzyme replacement therapy being developed to treat a severe, rare metabolic disorder. SBC-106 is a protein therapy that targets a severe and rare genetic condition.
Advisors' Opinion:- [By Garrett Cook]
Shares of Synageva BioPharma (NASDAQ: GEVA) were down 14.42 percent to $89.69 after the company reported that Phase 3 study met primary endpoint and six secondary endpoints across multiple disease-related abnormalities. Citigroup initiated coverage on Synageva BioPharma with a Neutral rating.
Top Oil Service Stocks To Watch Right Now: Apache Corporation(APA)
Apache Corporation, together with its subsidiaries, engages in the exploration, development, and production of natural gas, crude oil, and natural gas liquids. The company has exploration and production interests in the Gulf of Mexico, the Gulf Coast, east Texas, the Permian basin, the Anadarko basin, and the Western Sedimentary basin of Canada; and onshore Egypt, offshore Western Australia, offshore the United Kingdom in the North Sea, and onshore Argentina, as well as on the Chilean side of the island of Tierra del Fuego. Apache Corporation sells its natural gas to local distribution companies, utilities, end-users, integrated oil and gas companies, and marketers; and crude oil to integrated oil companies, marketing and transportation companies, and refiners. As of December 31, 2009, it had total estimated proved reserves of 1,067 million barrels of crude oil, condensate, and natural gas liquids, as well as 7.8 trillion cubic feet of natural gas. The company was founded in 1954 and is based in Houston, Texas.
Advisors' Opinion:- [By Arjun Sreekumar]
Others, however, are focusing their efforts on onshore U.S. shale plays, where resource potential is often more certain and risks are considerably lower than they are in, say, the Arctic. One such company is Houston-based Apache Energy (NYSE: APA ) , an independent oil and gas company with assets that span the U.S. and Canada, as well as Egypt, Australia, Argentina, and the U.K. North Sea.
Top Oil Service Stocks To Watch Right Now: Onyx Service & Solutions Inc (ONYX)
Onyx Service & Solutions, Inc., incorporated on November 25, 2009, focuses on energy solutions. The Company is a solar products manufacturer and supplier. Utilizing Polycrystalline silicon, with 72 cells in series, it provides 240 watt, 245 watt, 250 watt, 255 watt, 260 watt, 265 watt, 270 watt, 275 watt and 280 watt configurations. Its 72 cell panel size is 1955 x 992 x 50 millimeters. It also provides panels, which utilize 54 cells in series for 200 watt, 205 watt, 210 watt and 215 watt configurations. The Company is also a provider of both privately-owned and company-owned automatic teller machines (ATM��), in Onondaga County in upstate New York. The Company receives revenues from the collection of the surcharge revenues and inter-exchange revenues. As of July 31, 2011, it owned three ATMs and manages 19 ATMS throughout upstate New York. On August 22, 2011, the Company acquired Southern Geo Power Corp. (SGPC).
The Company�� 54 cell panel size is 1482 x 992 x 50 millimeters. ONYX/Optimum Solar silicon ingots are provided in both Monocrystalline and Polycrystalline versions. Its ingots are P type with Boron dopant. ONYX/Optimum solar silicon wafers are Polycrystalline solar cell materials. Its wafers are provided in the 156 x 156 millimeter size with a thickness of 220 micrometer/ 220 micrometer +/- 40 micrometer. ONYX/Optimum Solar cells are crystalline materials. It offers two models of solar cells, its Mono five inches (R150) 125S and its Mono five inches (R165) 125SL. Its R150 125S delivers 10 different levels of efficiency and its R165 125SL delivers 11 different levels of efficiency. ONYX Solar Air Conditioning Units offer thermal solar, as well as photovoltaic alternate current (AC) technology solutions. ONYX Solar Street Lights employed for both surface road and elevated highway use, in single or multiple unit setups. Its solar street lights are replenished within the sunlit hours of the day, enabling sustained performance throughout the night.
ONYX Solar Desalin! ization Systems are driven by means of photovoltaic panels, making use of pressure pumps, which force sea water across a membrane filtration system. ONYX/Optimum Solar 300 watt grid-tied micro photovoltaic inverter model OSI-300 is designed for superior installation, functionality and field maintenance. ONYX Solar Photovoltaic (PV) Glass is able to supply power to any given location with access to sunlight. ONYX Solar Well-Water Pump Systems are available in four energy options for use in a range of functions. Its solar well water pump systems were developed for virtual maintenance-free operation, rendering these units as solution for usage throughout isolated regions, including those without an electricity infrastructure readily available. ONYX Solar�� Vertical Vane Wind Turbines thrive on their ability to deliver energy from the smallest of application sites with the most stringent requirements. Each unit is able to deliver six kilowatts of power and may be used in multi-unit configurations. Onyx Solar�� Attic Fans operate within attic room setup, delivering needed aid in overall temperature regulation of the entire home or industrial/commercial building. Each fan supplies a steady exchange rate of 1600 cubic feet per minute.
Advisors' Opinion:- [By Lee Jackson]
Amgen Inc. (NASDAQ: AMGN) is a company doing the acquiring. The company recently completed a $10.4 billion purchase of Onyx Pharmaceuticals Inc. (NASDAQ: ONYX) to add its cancer drug Kyprolis to its already sprawling portfolio. UBS has a $124 price target on the stock. The consensus target is at $123. Investors are paid a 1.7% dividend.
Top Oil Service Stocks To Watch Right Now: Hansen Medical Inc.(HNSN)
Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and control of catheters and catheter-based technologies. The company?s products comprise the Sensei Robotic Catheter System and its related Artisan and Lynx catheters. It offers Sensei Robotic Catheter systems and Artisan catheters for manipulation, positioning, and control of mapping catheters during electrophysiology procedures. The company also provides robotic platforms consisting of the Magellan Robotic System and the NorthStar Robotic Catheter for the treatment of vascular disease. In addition, it offers CoHesion 3D Visualization Module, a software interface that provide physicians with 3D visualization to augment their ability to move a catheter throughout the heart, as well as control the placement of the catheter in specific locations. The company sells its products through direct sales force in the United States; and through direct sales force and dis tributors primarily in the European Union and internationally. It has a joint development agreement and co-marketing agreement with St. Jude Medical, Inc. for the development of CoHesion 3D Visualization Module; and a collaboration agreement with Philips Medical Systems Nederland B.V. to co-develop integrated products for use in the diagnosing and treatment of arrhythmias. The company was founded in 2002 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Roberto Pedone]
One health care player that insiders are active in here is Hansen Medical (HNSN), which develops, manufactures and markets new generation of medical robotics for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Insiders are buying this stock into relative weakness, since shares are off by 19.2% so far in 2013.
Hansen Medical has a market cap of $113 million and an enterprise value of $118 million. This stock trades at a premium valuation, with a price-to-sales of 7.13. Its estimated growth rate for this year is -3%, and for next year it's pegged at 36.2%. This is not a cash-rich company, since the total cash position on its balance sheet is $21.08 million and its total debt is $29.57 million.
A beneficial owner just bought 8.1 million shares, or about $9.96 million worth of stock, at $1.23 per share.
From a technical perspective, HNSN is currently trending above its 50-day and just below is 200-day moving average, which is neutral trendwise. This stock recently spiked up sharply from its low of $1.14 to its recent high of $1.96 a share with big upside volume. Since that move, shares of HNSN have pulled back and started to consolidation between $1.77 and $1.60 a share. This stock is now starting to bounce higher and move within range of triggering a near-term breakout trade.
If you're bullish on HNSN, then look for long-biased trades as long as this stock is trending some key near-term support levels at $1.60 to its 50-day at $1.51, and then once it breaks out above some near-term overhead resistance levels at $1.77 to $1.96 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 530,653 shares. If that breakout hits soon, then HNSN will set up to re-test or possibly take out its next major overhead resistance levels at $2.15 to $2.23 a share. Any high-volume move above those levels will then gi
